Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01237392 · ClinicalTrials.gov registry record · NA
Ultrasonic Wound Debridement vs. Standard Sharp Debridement
A NA study of Chronic Skin Ulcers, sponsored by Calvary Hospital, Bronx, NY.
- Completed
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT01237392 is a NA study of Chronic Skin Ulcers that has completed, run by Calvary Hospital, Bronx, NY. The registered enrollment target is 75 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01237392, a NA study of Chronic Skin Ulcers, has completed, sponsored by Calvary Hospital, Bronx, NY.
- COMPLETED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
A single center, randomized, parallel, clinical outcome trial to compare the rate of healing in chronic wounds debrided with either high energy ultrasonic debridement (with cavitation) or standard of care sharp debridement.
Conditions Studied
Interventions
- DEVICE Contact ultrasonic debridement device
Study Locations (1)
New York
- Calvary Hospital Center for Curative and Palliative Wound Care - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2008-06 |
| Est. Completion | 2011-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01237392
The ClinicalTrials.gov registry entry for NCT01237392 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Calvary Hospital, Bronx, NY, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Skin Ulcers appearing as the primary indexed condition, and to 1 intervention - of which Contact ultrasonic debridement device is the first listed.
NCT01237392 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01237392 about?
NCT01237392 is a clinical study titled "Ultrasonic Wound Debridement vs. Standard Sharp Debridement". A single center, randomized, parallel, clinical outcome trial to compare the rate of healing in chronic wounds debrided with either high energy ultrasonic debridement (with cavitation) or standard of care sharp debridement.
What is the current status of trial NCT01237392?
This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2008-06. Estimated completion is 2011-04.
What conditions does trial NCT01237392 study?
This clinical trial studies the following conditions: Chronic Skin Ulcers.
What interventions are being tested in trial NCT01237392?
The interventions under investigation include: Contact ultrasonic debridement device (DEVICE).
Who is sponsoring clinical trial NCT01237392?
This trial is sponsored by Calvary Hospital, Bronx, NY, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01237392 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.